MELISSA DENNISTON: Open Payments
NPI 1083449995 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 46 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $384 |
| Janssen Pharmaceuticals, Inc | 4 | $189 |
| Otsuka America Pharmaceutical, Inc. | 5 | $182 |
| Axsome Therapeutics, Inc. | 4 | $149 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Alkermes, Inc. | 5 | $96 |
| Indivior Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $36 |
Products named: VRAYLAR, INVEGA SUSTENNA, Auvelity, ABILIFY MAINTENA, Qelbree, AUSTEDO XR, ARISTADA, SUBLOCADE.
Industry payments across NJ — which companies pay providers there.
